Cargando…

Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?—A Systematic Review and Meta-Analysis

Background: The probable impact of a maintenance immunosuppressant (IS) on liver transplant (LT) recipients with coronavirus disease 2019 (COVID-19) remains unexplored. Our specific aim was to approximate the prognosis of LT recipients with COVID-19 on the standard maintenance IS. Method: We searche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Dipesh Kumar, Adhikari, Vishnu Prasad, Ling, Qi, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632009/ https://www.ncbi.nlm.nih.gov/pubmed/34859012 http://dx.doi.org/10.3389/fmed.2021.756922

Ejemplares similares

Antiviral prophylaxis or preemptive therapy for cytomegalovirus after liver transplantation?: A systematic review and meta-analysis
por: Yadav, Dipesh Kumar, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
por: Sripongpun, Pimsiri, et al.
Publicado: (2022)

Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes
por: Genuardi, Michael V., et al.
Publicado: (2021)

Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report
por: Mathiasen, Victor Dahl, et al.
Publicado: (2020)

Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations
por: Yadav, Dipesh Kumar, et al.
Publicado: (2020)

Involvement of liver in COVID-19: systematic review and meta-analysis
por: Yadav, Dipesh Kumar, et al.
Publicado: (2021)

Dermatological Disorders following Liver Transplantation: An Update
por: Yadav, Dipesh Kumar, et al.
Publicado: (2019)

Clinical outcomes of coronavirus disease 2019 in liver transplant recipients
por: Shafiq, Muhammad, et al.
Publicado: (2022)

Catastrophic Merkel Cell Carcinoma in a Liver Transplant Recipient
por: Isa, Rabab S, et al.
Publicado: (2023)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Coronavirus Disease 2019 in Lung Transplant Recipients
por: Gergen, Anna K., et al.
Publicado: (2021)

Lung Transplantation for Coronavirus Disease-2019 Patients and Coronavirus Disease-2019 in Lung Transplant Recipients
por: Avella, Diego, et al.
Publicado: (2023)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
por: Zhu, Lan, et al.
Publicado: (2020)

Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
por: Zhang, Hui, et al.
Publicado: (2020)

Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients
por: Kute, Vivek, et al.
Publicado: (2022)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
por: Liu, Fu-Chao, et al.
Publicado: (2017)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016)

Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2020)

Psychological Responses to the Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients
por: Zgoura, Panagiota, et al.
Publicado: (2020)

Risk of Severe Coronavirus Disease 2019 Infection in Kidney Transplant Recipients
por: Sacristán, Pilar Galindo, et al.
Publicado: (2022)

Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Liver Transplantation from Voluntary Organ Donor System in China: A Comparison between DBD and DCD Liver Transplants
por: Chen, Wei, et al.
Publicado: (2019)

Ondansetron causing near fatal catastrophe in a renal transplant recipient
por: Sahu, Sandeep, et al.
Publicado: (2011)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients
por: Aguiar, Diego, et al.
Publicado: (2017)

“SARS-CoV-2 Infection in Liver Transplant Recipients - Immunosuppression is the Silver Lining?”
por: Jadaun, Shekhar S., et al.
Publicado: (2022)

Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
por: Gu, Guangxiang, et al.
Publicado: (2023)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
por: Bremer, Sebastian C. B., et al.
Publicado: (2018)

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation
por: Dekeyser, Manon, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients
por: John, Binu V., et al.
Publicado: (2022)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f5563oc6hgem1vlvt039m9mo2c